Advertisement

Medical device company Teleflex touts 510(k) clearance for its Arrow UltraQuik peripheral nerve block needles.

Teleflex logo

Limerick, Pa.-based Teleflex (NYSE:TFX) won FDA clearance for the latest in its line of peripheral nerve block needles, the Arrow UltraQuik.

The Arrow UltraQuik joins Teleflex's StimuQuik and StimuQuik Echo, devices aimed at helping physicians perform nerve blocking, whether with ultrasound alone, via nerve stimulation, or through a combined approach, according to a press release.

Advertisement
Advertisement